NCT02891564

Brief Summary

Project:EVO is a video-game based intervention that targets neural networks associated with cognitive control. The same networks have been implicated in poor treatment response in middle and older aged adults suffering from major depression. Related work has demonstrated that healthy older adults show significant improvement in cognitive control. In a very small sample of older adults suffering from depression (n=12), we found similar improvements in selective attention and working memory after 4 weeks of intervention, along with improvements in mood comparable to participants receiving an evidence-based psychotherapy. The intent of this proposal is to first determine if at least 2/3 of participants who use Project:EVO for four weeks demonstrate significant improvements in the function of these neural networks, and if improvements are observed, to conduct a second study to see if changes in neural network functions are associated with changes in mood. If we show that Project:EVO improves neural function and mood to a greater degree than a placebo cognitive training game, we will be in a position to move onto the next phase of study, which is to demonstrate the intervention's efficacy in a much larger sample of adults with depression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 1, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 7, 2016

Completed
2.3 years until next milestone

Study Start

First participant enrolled

January 2, 2019

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2022

Completed
Last Updated

December 21, 2022

Status Verified

December 1, 2022

Enrollment Period

3.1 years

First QC Date

September 1, 2016

Last Update Submit

December 19, 2022

Conditions

Keywords

therapeutic video games, mobile interventions

Outcome Measures

Primary Outcomes (3)

  • CCN Function (Circuitry and Performance)

    \- Assess pre-post treatment change in activation (percent signal Δ) during the stroop/flanker test

    8 weeks

  • CCN Function (Self-Report- Disability)

    \- Pre-post self-report assessment of disability via WHO Disability Assessment Scale (36-item)

    8 weeks

  • CCN Function (Self-Report- Depressive Symptoms)

    \- Pre-post self-report assessment of depressive symptoms via Hamilton Depression Rating Scale (24-item)

    8 weeks

Study Arms (2)

Control Arm (R 33)

PLACEBO COMPARATOR

a mobile 3D video game to be used as placebo.

Other: Control Mobile 3D video game

Intervention Arm (R 33)

EXPERIMENTAL

a mobile 3D video game (Band Together) that has been shown to reduce older adults' susceptibility to interference by augmenting sustained attention and working memory abilities (e.g. cognitive control) through targeted adaptive algorithms.

Behavioral: Band Together

Interventions

Band TogetherBEHAVIORAL

a mobile 3D video game that has been shown to reduce older adults' susceptibility to interference by augmenting sustained attention and working memory abilities (e.g. cognitive control) through targeted adaptive algorithms. This game is analogous to Project: EVO.

Intervention Arm (R 33)

expectancy-matched control game

Control Arm (R 33)

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • (1) Age 45 to 75; (2) unipolar, nonpsychotic major depression (by SCID, DSM-V), (3) Hamilton Depression Rating Scale \> 20; (4) off antidepressants or have been on a stable dose for 12 weeks and do not intend to change dose in the next 5 weeks, (5) capacity to consent; (6) ability to participate in MRI.

You may not qualify if:

  • \) Intent or plan to attempt suicide in the near future; 2) history or presence of psychiatric diagnoses other than unipolar, non-psychotic major depression or generalized anxiety disorder; 3) use of psychotropic drugs or cholinesterase inhibitors other than mild doses of benzodiazepines 4) dementia or MCI (please see Human Subjects). Participants with an MMSE score falling 1 SD below the mean score for their age and education will be excluded as well.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Weill-Cornell Medical Center

White Plains, New York, 10605, United States

Location

University of Washington Department of Psychiatry and Behavioral Sciences

Seattle, Washington, 98195, United States

Location

MeSH Terms

Conditions

Depressive Disorder, Major

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Study Officials

  • Patricia A Arean, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Randomized Control Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Psychiatry and Behavioral Sciences

Study Record Dates

First Submitted

September 1, 2016

First Posted

September 7, 2016

Study Start

January 2, 2019

Primary Completion

January 20, 2022

Study Completion

January 20, 2022

Last Updated

December 21, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will share

We will make de-identified data available to all parties interested.

Locations